Betahistine in the treatment of vertiginous syndromes: a meta-analysis.

@article{Pepa2006BetahistineIT,
  title={Betahistine in the treatment of vertiginous syndromes: a meta-analysis.},
  author={C della Pepa and Giulia Guidetti and Mario Eandi},
  journal={Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale},
  year={2006},
  volume={26 4},
  pages={208-15}
}
Vertigo is a very frequent disorder, associated with highly disabling symptomatology. Since the aetiology cannot always be easily identified, treatment is often addressed to the symptoms. Betahistine, a drug characterized by a multi-factorial mode of action of the modulatory type, has been widely employed in the management of various vertiginous syndromes. Its use in Italy is, currently, authorized to treat the vertiginous symptoms related to Ménière's disease. A meta-analysis has, therefore… CONTINUE READING
11 Citations
15 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Betahistine bij de behandeling van aanyalsgewijs optredende duizeligheid . Een dubbelblind onderzoek

  • Fischer AJEM, Van Elferen LWM
  • JDR ( J Drug Therapy Res )
  • 1989

Betahistine versus placebo in paroxysmal vertigo ; a double - blind trial

  • WJ Oosterveld, W Blijleven, Van Elferen LWM
  • Concours Med
  • 1988

Betahistine bij de behandeling van aanyalsgewijs optredende duizeligheid

  • Fischer AJEM, Van Elferen LWM
  • Een dubbelblind onderzoek. JDR (J Drug Therapy
  • 1985

Vertiges paroxystiques itératifs et Serc . Étude clinique contrôlée

  • F Legent, C Calais, D Cellier
  • J Laryngol Otol
  • 1984

Similar Papers

Loading similar papers…